Please Wait...

Meghan Harrington

Translation skills

Main profile

Meghan Harrington
Meghan Harrington, MS
VP, Head of Site & Patient Payments

Meghan Harrington, MS, is Bioclinica's VP, Head of Site & Patient Payments and is responsible for the development and service delivery of all Bioclinica Site & Patient Payments SaaS technology products. Meghan and her team work with Sponsors and CROs to successfully outsource and implement Business Process Outsourcing (BPO) and Self-Service technology engagements.

Meghan has over 15 years of experience in the healthcare, technology and life science industries, which lends itself to a unique appreciation for both the needs and challenges of delivering top technology-enabled services in global clinical trials. Meghan is a subject matter expert in clinical trial payments and frequently presents at industry conferences and events.

 

Register Now
 
 
 

 

Blogs

Site Payments Solutions

Site payments remain a challenge for sponsors – at Bioclinica, we have data to support this from our own Site & Patient Payments technology but also from surveys that we've conducted, most recently with FierceBiotech. A survey about site payments was distributed by FierceBiotech to sponsors in April 2018, and 149 sponsors responded.

Transformational Trends in Investigator Site Payments

At this year's DIA, I presented information about the pain points that the clinical trials industry is experiencing with regards to site payments as well as the trends that are currently occurring in this space – based on surveys, interviews and analysis of data in Bioclinica's Site & Patient Payments technology.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

David Scott, PhD, Bioclinica Dir Medical & Science Affairs, will present on longitudinal progression of DaTscan bin… https://t.co/CA1LnzLZBs
Bioclinica (4 hours ago)
In our latest blog post, we review the "burdens" of #CTMS implementation - and how better solutions address them.… https://t.co/vcyS2gvwpu
Bioclinica (5 days ago)
David Scott, PhD, Bioclinica Dir Medical & Science Affairs, will present on longitudinal progression of DaTscan bin… https://t.co/01liAxqx0J
Bioclinica (6 days ago)
Rapid implementation. Increased control & efficiency. Out-of-the-box configuration. Turn-key validation. Cost savin… https://t.co/XO53jwd2DV
Bioclinica (2 weeks ago)
David Scott, PhD, Bioclinica Dir Medical & Science Affairs, will present on longitudinal progression of DaTscan bin… https://t.co/ZtxVWMlznP
Bioclinica (2 weeks ago)
Bioclinica's #IRT uses an agile delivery methodology, which means flexible configuration and customization, and del… https://t.co/SRd2uNscWc
Bioclinica (2 weeks ago)